HIV-1 subtypes and response to combination antiretroviral therapy in Europe

WP Bannister, L Ruiz, C Loveday, S Vella, K Zilmer, Jesper Kjær, B Knysz, AN Phillips, A Mocroft, Jens Dilling Lundgren

    52 Citationer (Scopus)

    Abstract

    BACKGROUND: Combination antiretroviral therapy (cART) may vary in ability to suppress viral load and increase CD4+ T-cell count in people infected with different HIV-1 subtypes, possibly due to differences in resistance development. Antiretroviral drugs have predominantly been developed in Western Europe/North America on the basis of the most prevalent subtype, B. However, non-B subtypes are increasingly spreading worldwide. OBJECTIVE: To compare virological and immunological response to cART between patients infected with B and non-B subtypes across Europe. DESIGN: EuroSIDA prospective, observational cohort with 11,928 HIV-1-infected patients. METHODS: Response to cART was analysed in patients with subtypes determined pre-cART, via multivariable logistic regression on the first measurements 6–12 months after starting cART. A virological response was defined as a viral load <500 copies/ml and immunological response as a CD4+ T-cell count increase of ³100 cells/mm^3. RESULTS: Forty-five percent of patients were antiretroviral naive at initiation of cART. Virological suppression was achieved by 58% of 689 subtype-B-infected patients and 66% of 102 non-B-infected patients (P=0.159). After adjustment for potential confounders, there was no significant difference in odds of achieving virological suppression (non-B compared with B; odds ratio [OR]: 1.05, 95% confidence interval [CI]: 0.58-1.93, P=0.866). An immunological response was achieved by 43% of 753 B-infected patients and 48% of 114 non-B-infected patients (P=0.334). After adjustment, there was no significant difference in odds of an immunological response (OR: 1.17, 95% CI: 0.73–1.87, P=0.524). CONCLUSIONS: There was no evidence of significant differences in virological or immunological response to cART between patients infected with HIV-1 B and non-B subtypes.
    OriginalsprogEngelsk
    TidsskriftAntiviral Therapy
    Vol/bind11
    Udgave nummer6
    Sider (fra-til)707-715
    ISSN1359-6535
    StatusUdgivet - 2006

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'HIV-1 subtypes and response to combination antiretroviral therapy in Europe'. Sammen danner de et unikt fingeraftryk.

    Citationsformater